Skip to main content
Panacea Biotec Ltd. logo

Panacea Biotec Ltd. — Investor Relations & Filings

Ticker · PANACEABIO ISIN · INE922B01023 LEI · 3358001FA81ZQYDLO796 BSE.NS Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2024-06-07 Regulatory Filings
Country IN India
Listing BSE.NS PANACEABIO

About Panacea Biotec Ltd.

https://www.panaceabiotec.com

Panacea Biotec Ltd. is a research-driven health management company specializing in the development, manufacturing, and marketing of vaccines, biopharmaceuticals, and pharmaceutical formulations. The organization focuses on therapeutic segments including organ transplantation, nephrology, oncology, diabetes, and pain management. Its vaccine portfolio supports global immunization initiatives, addressing diseases such as polio and hepatitis B through partnerships with international health agencies. The company operates integrated research and development centers and manufacturing facilities that adhere to international quality standards. Panacea Biotec emphasizes the creation of innovative drug delivery systems and complex generics to improve patient outcomes. Its operations are characterized by a commitment to biotechnology-led medical solutions and the production of affordable, high-quality therapeutic products for diverse global markets.

Recent filings

Filing Released Lang Actions
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings Classification · 95% confidence The document is a formal report addressed to stock exchanges (NSE and BSE) regarding violations of the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details specific insider trading violations by a designated person and their immediate relative, including dates, transaction details, penalties imposed, and actions taken by the company. The document is regulatory in nature, reporting compliance issues and enforcement actions related to insider trading rules. It does not contain financial statements, earnings data, or management discussion of financial results. It is not an annual or quarterly report, nor an earnings release or investor presentation. It is a compliance and regulatory disclosure about insider trading violations and penalties. Such documents fall under Regulatory Filings (RNS) as they are regulatory announcements that do not fit other specific categories like Director's Dealing (DIRS) because it reports violations and penalties rather than just insider trades, nor is it a Remuneration or Governance report. The document length (6741 characters) and content confirm it is a detailed regulatory filing rather than a brief announcement or certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-06-07 English
Code of Conduct under SEBI(PIT) Reg., 2015
Regulatory Filings Classification · 95% confidence The document is a formal report addressed to stock exchanges regarding violations of the company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2015. It details insider trading violations by a designated person and their immediate relative, including transaction dates, share quantities, and penalties imposed. The document is regulatory in nature, reporting compliance issues and actions taken, rather than financial results, management commentary, or shareholder meeting materials. It does not contain financial statements or earnings data, nor is it a proxy, dividend, or capital change announcement. It is a compliance and regulatory disclosure related to insider trading violations, fitting best under Regulatory Filings (RNS) as it does not match other more specific categories.
2024-06-07 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges and depositories, providing details about shares dematerialized during May 2024. It references Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, and includes a certificate from the Registrar and Transfer Agent (RTA). The content is an official notification about share dematerialization status, not a financial report or analysis. The document length is 3390 characters, which is relatively short and primarily serves as a regulatory compliance communication. It does not contain financial statements, management discussion, or audit information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2024-06-07 English
Updates
Board/Management Information Classification · 100% confidence The document is a formal disclosure addressed to stock exchanges regarding the re-designation of a company executive, Mr. Ankesh Jain, as Whole-time Director of the company and its subsidiary. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosures about changes in management or board composition. The content focuses on management changes and does not contain financial data, audit information, or report publication details. The document length is short (2300 characters), and it is clearly an announcement of a management change rather than a full report or financial filing. Therefore, the appropriate classification is Board/Management Information (MANG).
2024-05-31 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed audited financial results for the quarter and year ended March 31, 2024, including comprehensive financial data such as total income, net profit/loss, equity share capital, earnings per share, and notes explaining exceptional items and going concern basis. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes financial tables and management commentary on financial performance. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is a full financial report rather than a brief announcement or certification. Therefore, this document is best classified as an Interim / Quarterly Report (IR).
2024-05-31 English
Financial Result Updates
Regulatory Filings
2024-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.